Yanbing Li
Clinical trials sponsored by Yanbing Li, explained in plain language.
-
Diabetes breakthrough? study tests new ways to keep blood sugar stable after intensive treatment
Disease control Not yet recruitingThis study aims to find the best long-term medication approach for people with type 2 diabetes who need better blood sugar control. Researchers will compare three different drug combinations in 324 patients who first receive short-term intensive insulin therapy. The main goal is …
Phase: PHASE4 • Sponsor: Yanbing Li • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New diabetes drug tested against standard treatment in major Real-World trial
Disease control Not yet recruitingThis study aims to compare the effectiveness and safety of two diabetes medications, cofrogliptin and linagliptin, when added to insulin therapy. It will follow nearly 600 Chinese adults with type 2 diabetes whose blood sugar isn't well controlled on their current treatment. The …
Sponsor: Yanbing Li • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC